Browsing Tag
artificial intelligence
633 posts
Is Sarvam AI becoming India’s answer to Big Tech foundational models?
Discover how Sarvam AI is shaping India’s sovereign AI strategy and why indigenous foundational models are becoming critical national infrastructure.
Why the Tata Group’s OpenAI deal is really about compute power, not chatbots
Tata Group and OpenAI strike a landmark partnership spanning AI infrastructure, agentic solutions, and workforce skilling. Find out what this means for India and global enterprises.
Why LiveRamp’s (NYSE: RAMP) Scowtt deal signals a bigger bet on first-party data performance
Discover how LiveRamp Inc.’s partnership with Scowtt and its AI marketplace strategy could reshape advertising optimization and investor expectations.
From hype to hard data: Cushman & Wakefield unveils first scorecard tracking AI’s real impact on property markets
Discover how Cushman & Wakefield’s AI Impact Barometer turns artificial intelligence from hype into hard data shaping global real estate markets.
Google unveils Gemini 3.1 Pro and signals a turning point in artificial intelligence reasoning
Find out why Google’s Gemini 3.1 Pro signals a major shift in artificial intelligence reasoning and what it means for enterprises, developers, and investors.
From clinical bets to signature intelligence: is CDT Equity Inc. building an AI-backed asset engine?
CDT Equity Inc. invests $115M in Sarborg to build an AI-backed asset engine. Explore dilution risks, governance questions, and strategic upside.
Figma (NYSE: FIG) shares surge 14% premarket as revenue outlook and AI strategy reset investor expectations
Figma Inc. shares jumped 14 percent premarket after strong revenue guidance and clear artificial intelligence monetisation plans. Find out what this means for investors.
Claude Sonnet 4.6 signals a shift toward affordable frontier AI as Anthropic redraws the enterprise adoption curve
Claude Sonnet 4.6 brings near-Opus AI performance at lower cost. Find out how this shift could redefine enterprise AI adoption and pricing dynamics.
Capgemini (EPA: CAP) accelerates AI-led growth in FY2025 as bookings, margins, and outlook reset investor expectations
Capgemini’s FY2025 results reveal accelerating AI-driven growth, major acquisitions, and a bold 2026 outlook. Find out what it means for investors.
Neurophet bags third FDA 510(k) clearance as AI imaging tools move closer to frontline Alzheimer’s care decisions
Neurophet wins FDA clearance for AQUA AD Plus, strengthening its U.S. strategy as AI imaging becomes central to Alzheimer’s treatment decisions. Read more.